|
|
||||||||
Departments of 1Internal Medicine, 2Clinical Chemistry, and 3Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands
Submitted 3 December 2004 ; accepted in final form 15 February 2005
Type II deiodinase (D2) is important in the regulation of local thyroid hormone bioactivity in certain tissues. D2 in skeletal muscle may also play a role in serum triiodothyronine (T3) production. In this study, we identified a polymorphism in the 5'-UTR of the D2 gene (D2-ORFa-Gly3Asp). We investigated the association of D2-ORFa-Gly3Asp, and of the previously identified D2-Thr92Ala polymorphism, with serum iodothyronine levels. D2-ORFa-Gly3Asp was identified by sequencing the 5'-UTR of 15 randomly selected individuals. Genotypes for D2-ORFa-Gly3Asp were determined in 156 healthy blood donors (age 46.3 ± 12.2 yr) and 349 ambulant elderly men (age 77.7 ± 3.5 yr) and related to serum iodothyronine and TSH levels. D2-ORFa-Asp3 had an allele frequency of 33.9% in blood bank donors and was associated with serum thyroxine (T4; Gly/Gly vs. Gly/Asp vs. Asp/Asp = 7.06 ± 0.14 vs. 6.74 ± 0.15 vs. 6.29 ± 0.27 µg/dl, P = 0.01), free T4 (1.22 ± 0.02 vs. 1.16 ± 0.02 vs. 1.06 ± 0.04 ng/dl, P = 0.001), reverse T3 (P = 0.01), and T3/T4 ratio (P = 0.002) in a dose-dependent manner, but not with serum T3 (P = 0.59). In elderly men, D2-ORFa-Asp3 had a similar frequency but was not associated with serum iodothyronine levels. This new polymorphism in the 5'-UTR of D2 is associated with iodothyronine levels in blood donors but not in elderly men. We hypothesize that this might be explained by the decline in skeletal muscle size during aging, resulting in a relative decrease in the contribution of D2 to serum T3 production.
iodothyronines; open reading frame; population; association
This article has been cited by other articles:
![]() |
I. Meulenbelt, J. L. Min, S. Bos, N. Riyazi, J. J. Houwing-Duistermaat, H.-J. van der Wijk, H. M. Kroon, M. Nakajima, S. Ikegawa, A. G. Uitterlinden, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis Hum. Mol. Genet., June 15, 2008; 17(12): 1867 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Cooper Thyroxine Monotherapy After Thyroidectomy: Coming Full Circle JAMA, February 20, 2008; 299(7): 817 - 819. [Full Text] [PDF] |
||||
![]() |
P. S. Hansen, T. H. Brix, I. Iachine, T. I. A. Sorensen, K. O. Kyvik, and L. Hegedus Genetic and environmental interrelations between measurements of thyroid function in a healthy Danish twin population Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E765 - E770. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ortega, N. Pannacciulli, C. Bogardus, and J. Krakoff Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons Am. J. Clinical Nutrition, February 1, 2007; 85(2): 440 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P Peeters, W. M van der Deure, and T. J Visser Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur. J. Endocrinol., November 1, 2006; 155(5): 655 - 662. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |